BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6830691)

  • 1. The effects of regional factors on the growth rate and the differentiation of mouse teratocarcinoma.
    Oosterhuis JW; Bagasra O; Kushner H; Fox N; Damjanov I
    Br J Cancer; 1983 Mar; 47(3):407-11. PubMed ID: 6830691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice.
    Gordeeva OF; Nikonova TM
    Cell Transplant; 2013; 22(10):1901-14. PubMed ID: 23051679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.
    Martin GR
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7634-8. PubMed ID: 6950406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Teratocarcinoma of the mouse: isolation, culture and properties of pluripotential cells].
    Jakob H; Boon T; Gaillard J; Nicolas J; Jacob F
    Ann Microbiol (Paris); 1973 Oct; 124(3):269-82. PubMed ID: 4599372
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of the growth and differentiation of teratocarcinoma OC15S1 in syngeneic and allogeneic mice].
    Dyban PA
    Biull Eksp Biol Med; 1984 Jan; 97(1):71-2. PubMed ID: 6692027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone-forming cell line derived from embryonal carcinoma cells.
    Nicolas JF; Gaillard J; Jakob H; Jacob F
    Nature; 1980 Aug; 286(5774):716-8. PubMed ID: 6931966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
    Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
    Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and differentiation of an embryonal carcinoma cell line (C145b).
    Papaioannou VE; Evans EP; Gardner RL; Graham CF
    J Embryol Exp Morphol; 1979 Dec; 54():277-95. PubMed ID: 528871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nullipotent teratocarcinoma cells acquire the pluripotency for differentiation by fusion with somatic cells.
    Atsumi T; Shirayoshi Y; Takeichi M; Okada TS
    Differentiation; 1982; 23(1):83-6. PubMed ID: 7152170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and histology of a human mammary-carcinoma cell line at different sites in the athymic mouse.
    Levy JA; White AC; McGrath CM
    Br J Cancer; 1982 Mar; 45(3):375-83. PubMed ID: 7073933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluripotent teratocarcinoma-thymus somatic cell hybrids.
    Miller RA; Ruddle FH
    Cell; 1976 Sep; 9(1):45-55. PubMed ID: 61820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teratocarcinoma: neoplastic lessons about normal embryogenesis.
    Damjanov I
    Int J Dev Biol; 1993 Mar; 37(1):39-46. PubMed ID: 8507568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic cell hybrids between totipotent mouse teratocarcinoma and rat hepatoma cells.
    Litwack G; Croce CM
    J Cell Physiol; 1979 Oct; 101(1):1-8. PubMed ID: 44296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-fetoprotein in tumours derived from cystic and simple embryoid bodies.
    Monzó M; de Anta JM; Peris B; Ruano D
    Arch Ital Anat Embriol; 1991; 96(2):113-20. PubMed ID: 1725250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of age and sex of host mice on growth and differentiation of teratocarcinoma OTT6050.
    Kubota K; Kubota R; Takeda S; Matsuzawa T
    Exp Gerontol; 1981; 16(5):371-84. PubMed ID: 7318969
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth and differentiation of pluripotent embryonal carcinoma cells in the Snell dwarf mouse.
    van der Kamp AW; van Buul-Offers SC; Roza-de Jongh EJ; Feijlbrief M; Branger J; van Rongen E
    Br J Cancer; 1984 Oct; 50(4):479-82. PubMed ID: 6534385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratocarcinoma stem cells as a model for differentiation in the mouse embryo.
    Lehtonen E; Laasonen A; Tienari J
    Int J Dev Biol; 1989 Mar; 33(1):105-15. PubMed ID: 2485690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogen on the growth of mouse teratocarcinoma OTT6050 in vivo.
    Kubota K; Kubota R; Matsuzawa T
    Oncodev Biol Med; 1983; 4(5):309-17. PubMed ID: 6856482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and differentiation of teratocarcinoma OTT6050 affected by host hormonal changes in old mice.
    Kubota K; Kubota R; Matsuzawa T
    Tohoku J Exp Med; 1987 Mar; 151(3):253-9. PubMed ID: 3590172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.